Wallace Capital Management’s Amgen AMGN Stock Holding History

Wallace Capital Management's AMGN Position: Q2 2026 in Review

Wallace Capital Management increased its Amgen (AMGN) stake by 63% in Q2 2026, buying an estimated $155K and bringing the position to 1,171 shares worth $424K. The position accounts for 0.05% of the portfolio, ranked #59.

Wallace Capital Management first reported a position in AMGN in Q4 2019 and has held it in 7 quarters since. 3,158 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

• Wallace Capital Management held 1,171 shares of Amgen worth $424K as of Q2 2026.
• Wallace Capital Management bought 452 Amgen shares in Q2 2026, an estimated $155K.
• Amgen made up 0.05% of Wallace Capital Management's portfolio in Q2 2026, its #59 holding.
• Wallace Capital Management first reported a position in Amgen in Q4 2019 and has held it in 7 quarters since.
• 3,158 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Wallace Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.